AU2011293625B2 - Synbiotic product - Google Patents
Synbiotic product Download PDFInfo
- Publication number
- AU2011293625B2 AU2011293625B2 AU2011293625A AU2011293625A AU2011293625B2 AU 2011293625 B2 AU2011293625 B2 AU 2011293625B2 AU 2011293625 A AU2011293625 A AU 2011293625A AU 2011293625 A AU2011293625 A AU 2011293625A AU 2011293625 B2 AU2011293625 B2 AU 2011293625B2
- Authority
- AU
- Australia
- Prior art keywords
- product
- synbiotic
- probiotic
- synbiotic product
- spore
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 235000019722 synbiotics Nutrition 0.000 title claims abstract description 140
- 239000006041 probiotic Substances 0.000 claims abstract description 98
- 235000018291 probiotics Nutrition 0.000 claims abstract description 98
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 93
- 230000000529 probiotic effect Effects 0.000 claims abstract description 85
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 79
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 43
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 239000000835 fiber Substances 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 27
- 241001465754 Metazoa Species 0.000 claims abstract description 23
- 240000008042 Zea mays Species 0.000 claims abstract description 19
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 19
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 19
- 235000005822 corn Nutrition 0.000 claims abstract description 19
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 15
- 241000124008 Mammalia Species 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims description 66
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 14
- 241000194103 Bacillus pumilus Species 0.000 claims description 12
- 241000194108 Bacillus licheniformis Species 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 241000282898 Sus scrofa Species 0.000 claims description 3
- 235000002198 Annona diversifolia Nutrition 0.000 claims description 2
- 241000283726 Bison Species 0.000 claims description 2
- 241000283725 Bos Species 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims description 2
- 241000283086 Equidae Species 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 claims description 2
- 241000282838 Lama Species 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 241001416177 Vicugna pacos Species 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 abstract description 92
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract description 52
- 229920000617 arabinoxylan Polymers 0.000 abstract description 45
- 241000894006 Bacteria Species 0.000 abstract description 40
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 abstract description 34
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 abstract description 33
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract description 27
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 27
- 229920001100 Polydextrose Polymers 0.000 abstract description 17
- -1 arabinoxylan oligosaccharides Chemical class 0.000 abstract description 17
- 239000001259 polydextrose Substances 0.000 abstract description 17
- 235000013856 polydextrose Nutrition 0.000 abstract description 17
- 229940035035 polydextrose Drugs 0.000 abstract description 17
- 229920001542 oligosaccharide Polymers 0.000 abstract description 14
- 229920001353 Dextrin Polymers 0.000 abstract description 9
- 239000004375 Dextrin Substances 0.000 abstract description 9
- 235000019425 dextrin Nutrition 0.000 abstract description 9
- 239000000047 product Substances 0.000 description 131
- 239000000306 component Substances 0.000 description 27
- 241000193749 Bacillus coagulans Species 0.000 description 23
- 239000000843 powder Substances 0.000 description 19
- 230000012010 growth Effects 0.000 description 18
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 235000016709 nutrition Nutrition 0.000 description 10
- 229920002488 Hemicellulose Polymers 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000035764 nutrition Effects 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 230000007407 health benefit Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 241001328122 Bacillus clausii Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 229920001202 Inulin Polymers 0.000 description 6
- 229940054340 bacillus coagulans Drugs 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 6
- 229940029339 inulin Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 241000736262 Microbiota Species 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 5
- 229960000511 lactulose Drugs 0.000 description 5
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 235000008452 baby food Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 208000037009 Vaginitis bacterial Diseases 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 229940059442 hemicellulase Drugs 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229960001005 tuberculin Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- 101000648554 Mus musculus Sushi domain-containing protein 6 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002389 Pouchitis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241001092355 Tetilla <sponge> Species 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000033847 bacterial urinary tract infection Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000001847 bifidogenic effect Effects 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010961 commercial manufacture process Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 108010041969 feruloyl esterase Proteins 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000021289 health related food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940066544 lactobacillus sporogenes Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021071 low fiber diet Nutrition 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000021140 nondigestible carbohydrates Nutrition 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/40—Mineral licks, e.g. salt blocks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015271936A AU2015271936A1 (en) | 2010-08-25 | 2015-12-18 | Synbiotic product |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37688810P | 2010-08-25 | 2010-08-25 | |
| US61/376,888 | 2010-08-25 | ||
| PCT/US2011/048392 WO2012027214A1 (en) | 2010-08-25 | 2011-08-19 | Synbiotic product |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015271936A Division AU2015271936A1 (en) | 2010-08-25 | 2015-12-18 | Synbiotic product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2011293625A1 AU2011293625A1 (en) | 2013-02-21 |
| AU2011293625B2 true AU2011293625B2 (en) | 2015-09-24 |
Family
ID=44533204
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011293625A Ceased AU2011293625B2 (en) | 2010-08-25 | 2011-08-19 | Synbiotic product |
| AU2015271936A Abandoned AU2015271936A1 (en) | 2010-08-25 | 2015-12-18 | Synbiotic product |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015271936A Abandoned AU2015271936A1 (en) | 2010-08-25 | 2015-12-18 | Synbiotic product |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9237763B2 (enExample) |
| EP (1) | EP2608678A1 (enExample) |
| JP (2) | JP2013537431A (enExample) |
| KR (1) | KR20130102541A (enExample) |
| CN (2) | CN103068254A (enExample) |
| AU (2) | AU2011293625B2 (enExample) |
| BR (1) | BR112013004194A2 (enExample) |
| CA (1) | CA2808495A1 (enExample) |
| IL (1) | IL224833A (enExample) |
| MX (1) | MX348937B (enExample) |
| WO (1) | WO2012027214A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010020639A1 (en) * | 2008-08-18 | 2010-02-25 | Bioactor Bvba | Arabinoxylans for modulating the barrier function of the intestinal surface |
| US9125935B1 (en) | 2011-05-31 | 2015-09-08 | Nutech Ventures | Probiotics and methods of obtaining same |
| CN104822277A (zh) * | 2012-11-29 | 2015-08-05 | 雀巢产品技术援助有限公司 | 合生元组合物及其用途 |
| PT2954041T (pt) | 2013-02-06 | 2018-10-22 | Envera Llc | Misturas de composto germinativo de esporo secas |
| EP2769625A1 (en) * | 2013-02-25 | 2014-08-27 | Cargill, Incorporated | Confectionery compositions |
| EP2769626A1 (en) * | 2013-02-25 | 2014-08-27 | Cargill, Incorporated | Chewing gum composition |
| GB201312713D0 (en) * | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
| BR112016008993B1 (pt) | 2013-10-25 | 2021-08-31 | Nch Corporation | Composição probiótica para tratar animais, plantas, ou camas para animais, sistema para administrar uma composição probiótica, e, método para aumentar populações bacterianas benéficas nos tratos gastrointestinais de animais |
| US10766799B2 (en) | 2014-05-23 | 2020-09-08 | Nch Corporation | Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method |
| PE20170238A1 (es) | 2014-05-23 | 2017-04-05 | Nch Corp | Metodo para la mejora de la calidad del agua de estanques para acuicultura |
| EP2805630A1 (en) * | 2014-09-25 | 2014-11-26 | Cargill, Incorporated | Carbohydrate compositions |
| WO2017063909A1 (en) | 2015-10-13 | 2017-04-20 | Unilever N.V. | A process for preparing metabolites by reaction of a prebiotic component with a probiotic component |
| CA3019732A1 (en) | 2016-04-05 | 2017-10-12 | Nch Corporation | Nutrient rich germinant composition and spore incubation method |
| US10897922B2 (en) | 2016-04-05 | 2021-01-26 | Nch Corporation | Composition and method for germinative compounds in probiotic food and beverage products for human consumption |
| US12097226B2 (en) | 2016-04-05 | 2024-09-24 | Nch Corporation | System and method for using a single-serve nutrient spore composition for small scale farm applications |
| CN106689798B (zh) * | 2016-11-17 | 2021-03-30 | 大连理工大学 | 海洋合生元添加剂及其制备方法与在刺参养殖中的应用 |
| CN110582209A (zh) * | 2017-04-10 | 2019-12-17 | 基博生物技术公司 | 用于消化系统健康，控制体重，增强免疫力和改善健康的多纤维益生元组合物 |
| CN107198250B (zh) * | 2017-05-23 | 2019-03-12 | 北京瑞千景科技发展有限公司 | 改善肠道微生态预防慢性病组合物和均衡营养食品及应用 |
| WO2019147799A1 (en) | 2018-01-24 | 2019-08-01 | Omnigen Research, Llc | Bacillus combination for administration to animals |
| EP3749106A1 (en) * | 2018-02-06 | 2020-12-16 | Sutherland, Duncan-Bruce | Method of preparing prebiotic dietary fiber and probiotic-fibre complexes |
| US11401500B2 (en) | 2018-08-29 | 2022-08-02 | Nch Corporation | System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications |
| WO2020173963A1 (en) * | 2019-02-25 | 2020-09-03 | Servophil AG | Deposition reduction |
| WO2021055492A1 (en) * | 2019-09-16 | 2021-03-25 | Microbiome Labs, Llc | Spore-based probiotic supplementation in dogs and control of endotoxemia |
| WO2021159068A1 (en) | 2020-02-06 | 2021-08-12 | Nch Corportion | Composition and method of using germinative compounds in probiotics for inflammation reduction in humans |
| US20230148645A1 (en) | 2020-04-09 | 2023-05-18 | Prabhakaran PANDURANGAN | Therapeutic composition |
| CA3184420A1 (en) * | 2020-06-30 | 2022-01-06 | Mark C. Faulkner | Compositions and methods for treatment of vaginal infections |
| CN112753988A (zh) * | 2021-01-22 | 2021-05-07 | 上海沛藤生物工程有限公司 | 一种利用芽孢杆菌的小包装甜味剂及其制备方法 |
| TR2022004759A2 (tr) * | 2022-03-28 | 2022-04-21 | Sayar Organik Biyolojik Ueruenler Imalat Sanayi Ve Ticaret Ltd Sirketi | Bacillus subtilis bakteri̇ ai̇lesi̇ i̇çeri̇kli̇ bi̇yoteknoloji̇k ürün |
| KR20250105751A (ko) | 2023-12-29 | 2025-07-09 | 매일유업 주식회사 | 모유 올리고당 혼합물 및 프로바이오틱 균주를 유효성분으로 포함하는 신바이오틱 조성물 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010015580A1 (en) * | 2008-08-04 | 2010-02-11 | Dsm Ip Assets B.V. | Production of beadlets comprising probiotic compounds |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110477A (en) | 1977-05-13 | 1978-08-29 | Kabushiki Kaisha Naruse Fermentation Laboratory | Method for producing natto containing lactic acid bacteria |
| JP2779963B2 (ja) | 1989-02-09 | 1998-07-23 | 株式会社林原生物化学研究所 | ビフィズス菌増殖促進剤 |
| US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| US6203797B1 (en) | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
| US6811786B1 (en) * | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
| EP1067945B1 (en) * | 1998-04-01 | 2006-01-04 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
| US6942754B2 (en) | 1999-03-23 | 2005-09-13 | Oji Paper Co., Ltd. | Process for producing xylooligosaccharide from lignocellulose pulp |
| US6849256B1 (en) | 1999-11-08 | 2005-02-01 | Ganeden Biotech Incorporated | Inhibition of pathogens by probiotic bacteria |
| EP1243273A1 (en) * | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| US20030077255A1 (en) | 2001-04-16 | 2003-04-24 | Sabharwal Hemant K. | Compositions of bacteria and alpha-lactalbumin and uses thereof |
| EP1446023B1 (en) | 2001-11-12 | 2009-02-25 | Mars, Incorporated | Foodstuff for cats and dogs |
| GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| CA2535951A1 (en) * | 2003-08-14 | 2005-03-03 | The Bio Balance Corporation | Bacterial strains, compositions including same and probiotic use thereof |
| US7759105B2 (en) | 2003-08-29 | 2010-07-20 | Cobb & Company, Llp | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| GB0414655D0 (en) * | 2004-06-30 | 2004-08-04 | Leuven K U Res & Dev | Prebiotic |
| RU2395218C2 (ru) | 2005-10-24 | 2010-07-27 | Нестек С.А. | Композиция пищевых волокон для профилактики или лечения заболеваний пищеварительной системы и композиция пищевых волокон, эффективная при лечении холеры |
| CN100360658C (zh) * | 2006-02-17 | 2008-01-09 | 哈尔滨美华生物技术股份有限公司 | 肠道微生态制剂及其制备方法 |
| CN101095698B (zh) * | 2006-06-26 | 2010-12-01 | 青岛东海药业有限公司 | 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途 |
| MX2009011696A (es) | 2007-05-23 | 2009-11-10 | Tate & Lyle Ingredients | Composicion comestible que comprende una composicion de oligosacarido resistente a la digestion o lentamente digestible. |
| CN101558824B (zh) * | 2008-04-15 | 2011-09-21 | 北京大北农科技集团股份有限公司 | 一种复合微生态制剂 |
| CN101744239A (zh) | 2008-12-01 | 2010-06-23 | 青岛东海药业有限公司 | 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用 |
| CN101449830B (zh) * | 2008-12-29 | 2012-01-11 | 山东龙力生物科技股份有限公司 | 一种添加合生元的中老年奶粉及其制备方法 |
| CN101537020B (zh) | 2009-04-24 | 2012-05-02 | 东北制药集团公司沈阳第一制药厂 | 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂 |
| EP2427499A1 (en) * | 2009-05-07 | 2012-03-14 | Tate&Lyle Ingredients France SAS | Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans |
| US12436408B2 (en) | 2022-11-11 | 2025-10-07 | Htc Corporation | Wearable device |
-
2011
- 2011-08-19 BR BR112013004194A patent/BR112013004194A2/pt not_active IP Right Cessation
- 2011-08-19 CA CA2808495A patent/CA2808495A1/en not_active Abandoned
- 2011-08-19 US US13/213,663 patent/US9237763B2/en active Active
- 2011-08-19 CN CN2011800396484A patent/CN103068254A/zh active Pending
- 2011-08-19 JP JP2013526038A patent/JP2013537431A/ja active Pending
- 2011-08-19 CN CN201710403213.2A patent/CN107251988A/zh active Pending
- 2011-08-19 WO PCT/US2011/048392 patent/WO2012027214A1/en not_active Ceased
- 2011-08-19 EP EP11749673.7A patent/EP2608678A1/en not_active Withdrawn
- 2011-08-19 KR KR1020137004175A patent/KR20130102541A/ko not_active Ceased
- 2011-08-19 MX MX2013002171A patent/MX348937B/es active IP Right Grant
- 2011-08-19 AU AU2011293625A patent/AU2011293625B2/en not_active Ceased
-
2013
- 2013-02-20 IL IL224833A patent/IL224833A/en active IP Right Grant
-
2015
- 2015-12-11 US US14/966,590 patent/US20160095343A1/en not_active Abandoned
- 2015-12-18 AU AU2015271936A patent/AU2015271936A1/en not_active Abandoned
-
2017
- 2017-02-24 JP JP2017033618A patent/JP2017113022A/ja not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010015580A1 (en) * | 2008-08-04 | 2010-02-11 | Dsm Ip Assets B.V. | Production of beadlets comprising probiotic compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| US20120052152A1 (en) | 2012-03-01 |
| CN103068254A (zh) | 2013-04-24 |
| EP2608678A1 (en) | 2013-07-03 |
| WO2012027214A1 (en) | 2012-03-01 |
| AU2011293625A1 (en) | 2013-02-21 |
| US9237763B2 (en) | 2016-01-19 |
| CN107251988A (zh) | 2017-10-17 |
| JP2013537431A (ja) | 2013-10-03 |
| KR20130102541A (ko) | 2013-09-17 |
| US20160095343A1 (en) | 2016-04-07 |
| CA2808495A1 (en) | 2012-03-01 |
| MX2013002171A (es) | 2013-04-05 |
| BR112013004194A2 (pt) | 2016-05-10 |
| AU2015271936A1 (en) | 2016-02-11 |
| JP2017113022A (ja) | 2017-06-29 |
| MX348937B (es) | 2017-07-03 |
| IL224833A (en) | 2017-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011293625B2 (en) | Synbiotic product | |
| US12110486B2 (en) | Bifidobacterium bacteria and composition including novel Bifidobacterium bacteria | |
| KR100857500B1 (ko) | 신규한 갈락토올리고사카라이드 조성물 및 그 제조방법 | |
| CN101415342B (zh) | 饮食用组合物 | |
| JP7240327B2 (ja) | 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物 | |
| Paseephol | Characterisation of prebiotic compounds from plant sources and food industry wastes: inulin from Jerusalem artichoke and lactulose from milk concentration permeate | |
| KR101848230B1 (ko) | 락토바실러스 균주의 안정성 증진을 위한 프리바이오틱스 조성물 및 이를 이용한 안정화 증진방법 | |
| CN119947600A (zh) | 改善健康的合生元治疗方法 | |
| CN101297679A (zh) | 一种提高畜禽免疫力的饲料添加剂及其制备方法 | |
| CN111955741B (zh) | 一种用于体重控制的组合物及其应用 | |
| CN110710627A (zh) | 一种功能性益生菌固体饮料及其制备方法 | |
| JP2018154612A (ja) | Ｆ／ｂ比低下用食品組成物、ｆ／ｂ比低下剤、アッカーマンシア・ムシニフィラ菌占有率増加用食品組成物及びアッカーマンシア・ムシニフィラ菌占有率増加剤 | |
| JP2016171814A (ja) | カテコールアミン認識性を指標に選抜した微生物とカテコールアミン含有組成物 | |
| WO2023150628A2 (en) | Probiotic strain selected by targeted in vivo enrichment to aid with healthy lactose digestion | |
| AU2013312981A1 (en) | Treatment of diarrhea and post-weaning diarrhea with resistant potato starch | |
| WO2018169011A1 (ja) | 腸内フローラバランス改善用食品組成物及び腸内フローラバランス改善剤 | |
| Oyetayo et al. | Preliminary study of the health promoting potentials of Lactobacillus fermentum OVL and plerotus Sajor caju administered to rats | |
| CN107693547A (zh) | 一种益生菌组合物的制备方法及用途 | |
| González-Ávila et al. | Evaluation of prebiotic potential of agave fructans from different regions of Colima and Zacatecas, Mexico. | |
| Masoud et al. | Effect of synbiotics fortification in specific baby food formulas on iron, calcium and zinc absorption | |
| JP2026002748A (ja) | ブラウティア属細菌を利用した腸内環境改善用組成物 | |
| CN120570389A (zh) | 一种具有减脂功效的益生菌组合物及其制备方法和应用 | |
| Sharon et al. | Banana flour as a substrate for the development of probiotic health foods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |